Story in NYT about new tests to help identify clinically significant prostate cancers

A story on the New York Times “Well” blog, posted yesterday afternoon, provides a useful overview of the evolving spectrum of diagnostic/prognostic tests that can help to differentiate between truly low-risk and higher-risk, clinically significant prostate cancers.

The story (by Roni Rabin) doesn’t get into a lot of detail about all the new and development stage tests, but it does point out the way the world of testing for risk of clinically significant prostate cancer is changing, with less dependence being placed on the PSA test alone and greater dependence being placed on appropriate patient work-up prior to decisions about actual treatment or simple monitoring.

2 Responses

  1. The link is not working

  2. Jean: The link has been fixed. Sorry.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: